101 related articles for article (PubMed ID: 7132736)
21. Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings.
Bassetti M; Arosio M; Spada A; Brina M; Bazzoni N; Faglia G; Giannattasio G
J Clin Endocrinol Metab; 1988 Dec; 67(6):1195-204. PubMed ID: 3142915
[TBL] [Abstract][Full Text] [Related]
22. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
23. Effects of extracerebral dopamine on salsolinol- or thyrotropin-releasing hormone-induced prolactin (PRL) secretion in goats.
Inaba Y; Kato Y; Itou A; Chiba A; Sawai K; Fülöp F; Nagy GM; Hashizume T
Anim Sci J; 2016 Dec; 87(12):1522-1527. PubMed ID: 26997651
[TBL] [Abstract][Full Text] [Related]
24. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
[TBL] [Abstract][Full Text] [Related]
25. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly.
Orio F; Iovino M; Monteleone P; Agrusta M; Steardo L; Lombardi G
Horm Metab Res; 1988 Nov; 20(11):701-4. PubMed ID: 2850985
[TBL] [Abstract][Full Text] [Related]
27. Role of aging on growth hormone and prolactin release after growth hormone-releasing hormone and domperidone in man.
Giusti M; Lomeo A; Marini G; Attanasio R; Barreca A; Camogliano L; Peluffo F; Giordano G
Horm Res; 1987; 27(3):134-40. PubMed ID: 3121487
[TBL] [Abstract][Full Text] [Related]
28. Somatotroph responsiveness to low dose dopamine infusion in normal subjects and acromegalic patients.
Serri O
Neuroendocrinology; 1986; 42(6):475-80. PubMed ID: 3010156
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.
Verde G; Chiodini PG; Liuzzi A; Cozzi R; Favales F; Botalla L; Spelta B; Dalla Bonzana D; Rainer E; Horowski R
J Endocrinol Invest; 1980; 3(4):405-14. PubMed ID: 6782153
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.
Goldman JA; Molitch ME; Thorner MO; Vale W; Rivier J; Reichlin S
J Endocrinol Invest; 1987 Aug; 10(4):397-406. PubMed ID: 3119697
[TBL] [Abstract][Full Text] [Related]
31. Diminished prolactin reserve in acromegaly.
Spitz IM; Barzilai D; Luboshitzky R
Metabolism; 1980 Sep; 29(9):880-4. PubMed ID: 6774202
[TBL] [Abstract][Full Text] [Related]
32. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
[TBL] [Abstract][Full Text] [Related]
33. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.
Werner S; af Trampe E; Palacios P; Lax I; Hall K
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1713-20. PubMed ID: 4030438
[TBL] [Abstract][Full Text] [Related]
35. Domperidone stimulates prolactin secretion in rats with complete destruction of the mediobasal hypothalamus.
Kiem DT; Nagy GM; Barna I; Makara GB
Brain Res Bull; 1997; 44(2):151-4. PubMed ID: 9292204
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of hypothalamic hyperprolactinemia.
Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
[TBL] [Abstract][Full Text] [Related]
37. Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
Hentschel K; Fleckenstein AE; Toney TW; Lawson DM; Moore KE; Lookingland KJ
Brain Res; 2000 Jan; 852(1):28-36. PubMed ID: 10661492
[TBL] [Abstract][Full Text] [Related]
38. Increased thyrotrophin and prolactin secretion induced by domperidone in hypothyroid subjects.
Massara F; Camanni F; Amoroso A; Molinatti GM; Müller EE
Acta Endocrinol (Copenh); 1981 May; 97(1):48-53. PubMed ID: 7223316
[TBL] [Abstract][Full Text] [Related]
39. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
40. The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly.
Giusti M; Lomeo A; Mazzocchi G; Mignone D; Sessarego P; Monachesi M; Giordano G
J Endocrinol Invest; 1985 Jun; 8(3):203-6. PubMed ID: 3928732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
